NEO
NEO
NASDAQ · Health Care

Neogenomics Inc

$11.42
+0.15 (+1.33%)
As of Feb 8, 1:38 PM ET ·
Income Statement
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Revenue 674.81M 608.48M 828.00M 759.46M 804.45M
Net Income -80,427,463 -65,270,258 61.91M 56.53M 50.19M
EPS
Profit Margin -11.9% -11.3% 7.5% 7.4% 6.2%
Rev Growth +10.9% +10.9% +11.0% -7.8% -8.3%
Balance Sheet
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
Total Debt 276.97M 276.97M 90.19M 99.64M 90.17M
Total Equity 461.84M 461.84M 930.30M 945.36M 961.54M
D/E Ratio 0.60 0.60 0.10 0.11 0.09
Cash Flow
FY 2026 FY 2025 FY 2025 FY 2024 FY 2023
EBITDA -57,888,106 -49,588,548 104.88M 95.37M 98.54M
Free Cash Flow 29.28M 21.30M 34.74M